Latest filing published 03 Jan 2007 for ALLOS THERAPEUTICS INC, €1,687.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Eric Malek: trading record in brief
Eric Malek discloses dealings in Allos Therapeutics Inc to SEC (Form 4). Over a trading history stretching from 30 December 2005 to 29 December 2006, the count stands at 3 filings.
No open-market sale appears; the market trades are 3 purchases worth €4,797. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2007: 1 purchase and no sales on the market.
Half of the purchases are above €1,687 and half below.
Most recently, on 3 January 2007, the filings show an open-market purchase worth €1,687 in Allos Therapeutics Inc. Typically, a trade is published a median of 5 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Eric Malek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,223 shares@ US$1.82Common StockSEC:0001097264-07-000007:0Canonical exit: 29 Mar 2007 (T+90)
- 1,209 shares@ US$1.82Common StockSEC:0001097264-06-000044:0Canonical exit: 28 Sept 2006 (T+90)
- 904 shares@ US$1.82Common StockSEC:0001097264-06-000006:0Canonical exit: 30 Mar 2006 (T+90)
3 of 3 declarations
